Boston Scientific announces results for third quarter 2025

Go back to Boston Scientific announces results for third quarter 2025

Stifel on Boston Scientific (BSX): 'We expect especially positive growth contributions from Watchman and Electrophysiology'

October 22, 2025 12:47 PM EDT

Stifel analyst Rick Wise reiterated a Buy rating and $125.00 price target on Boston Scientific (NYSE: BSX).

The analyst comments "Coming away from Boston Scientifics late September biennial Analyst meeting, we strongly felt that the companys 2026-2028 double-digit revenue growth outlook was highly credible... More